Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

VNDAVNDA
Showing 8 of 15 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in VANDA PHARMACEUTICALS INC

Yes. AQR Capital Management holds 3,497,695 shares of VNDA (Vanda Pharmaceuticals), worth $21.4M, as of its Q2 2026 13F filing. It increased the position by 1,894,119 shares (+118.1%) from Q1 2026. AQR Capital Management has held VNDA since Q4 2023, across 11 quarterly 13F filings.

Current Value

$21.4M

Current Shares

3.5M

Total Value Change

+$21.1M

Total Shares Change

+3.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.5M
+118.1%
$21.4M0.0%$6.12
46
2026-Q1
Increased
1.6M
+155.8%
$11.1M0.0%$6.91
45
2025-Q4
Decreased
627,006
-6.2%
$5.5M0.0%$8.82
0
2025-Q3
Increased
668,466
+392.5%
$3.3M0.0%$4.99
43
2025-Q2
Increased
135,724
+163.2%
$640,6160.0%$4.72
39
2025-Q1
Increased
51,560
+3.2%
$236,6600.0%$4.59
24
2024-Q4
Decreased
49,979
-24.2%
$239,4000.0%$4.79
0
2024-Q3
Decreased
65,923
-13.1%
$309,1790.0%$4.69
0

Other major holders of VNDA: RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used